There were no new HIV infections among adolescent girls and young women taking a new PrEP formulation, a twice-yearly shot of the drug lenacapavir.
Please follow and like us:
Science and Technolgy blog
There were no new HIV infections among adolescent girls and young women taking a new PrEP formulation, a twice-yearly shot of the drug lenacapavir.